Hudson Bay Capital Management »

Zentalis Pharmaceuticals shares owned by Hudson Bay Capital Management

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Hudson Bay Capital Management from 13F filings

Historical chart of Hudson Bay Capital Management investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by Hudson Bay Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by Hudson Bay Capital Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $274k 117k 2.34
2025-06-30 $19k 17k 1.16

More positions owned by Hudson Bay Capital Management

NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Amazon Call Option (AMZN)
Apple Call Option (AAPL)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Advanced Micro Devices Call Option (AMD)
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Berkshire Hathaway Inc Del Cl B New Put Option (BRK.B)
Microsoft Corporation Call Option (MSFT)
Echostar Corp Note 3.875%11/3 (Principal)
Taiwan Semiconductor Manufac Sponsored Ads Put Option (TSM)
Flagstar Bank National Assoc Com New (FLG)
UnitedHealth Put Option (UNH)

View all positions for Hudson Bay Capital Management

Top funds holding Zentalis Pharmaceuticals

Squadron Capital Management
5AM Venture Management
Two Sigma Investments
Renaissance Technologies
Vanguard Group
Acadian Asset Management
Vanguard Capital Management
Citadel Advisors
D. E. Shaw & Co
Opaleye Management
Decheng Capital
Millennium Management
BlackRock
Bank of America Corporation
PRIMECAP Management Company

View all funds holding Zentalis Pharmaceuticals